PATH
Menu

View slideshow

Where vaccines reach, children have a strong chance at surviving common illnesses, growing, and thriving.

Each year, immunization reaches 106 million children and protects 2.5 million from vaccine-preventable disease. Yet 24 million children still lack basic immunization, and new vaccines that reach the industrialized world may take years to become available in poor countries, if at all.

PATH works to close this gap and reach communities most in need with lifesaving solutions, from a shot that prevents cervical cancer to a revolutionary vaccine to protect millions in Africa against epidemic meningitis.
[View]

Vaccines are among the most successful and cost-effective public health interventions. PATH and our partners are working to bring vaccines against some of the most persistent illnesses to the world’s poorest communities.

Photo: PATH/Mike Wang.

[View]

In partnership with the World Health Organization, we developed a new vaccine against group A meningococcal meningitis—the first vaccine created specifically for Africa. The first mass vaccination campaigns reached nearly 20 million people. “We hope that meningitis is now history,” says Doma Guere, a nurse in Burkina Faso.

Photo: PATH/Gabe Bienczycki.

[View]

The deadliest form of malaria has plagued communities in Africa for centuries, but help may be near. PATH and GlaxoSmithKline are working toward a vaccine that could help protect the health of millions. In Tanzania, the first vaccinations in the Phase 3 trial of RTS,S were administered in Bagamoyo, under the leadership of Dr. Salim Abdulla, left.

Photo: PATH/David Poland.

[View]

These children in India hold much more than an immunization card in their hands. They hold hope for a healthier future. PATH helped the country introduce a vaccine against Japanese encephalitis in 2006. Nearly 75 million children in India have been vaccinated against the disease, and we’ve helped bring the vaccine to other countries in Asia.

Photo: PATH.

[View]

When budgets are tight, poor countries must prioritize which vaccines to buy. PATH generated crucial data on the costs and benefits of introducing a vaccine against Haemophilus influenzae type b (Hib), which kills about 4,000 babies each year. Such evidence helps Senegal and other countries make informed decisions about introduction.

Photo: Siri Wood.

[View]

PATH supported the GAVI Alliance's efforts to introduce rotavirus vaccines in Sudan, the first GAVI-eligible African country to immunize its children against the most deadly cause of childhood diarrhea.

Photo: GAVI/Doune Porter.

[View]

PATH looks for ways to shorten the time it takes new technologies to reach developing countries. In Africa, Asia, and Latin America, we evaluated new strategies for protecting girls against cervical cancer with a vaccine against human papillomavirus.

Photo: PATH/Amynah Janmohamed.

[View]

In Vietnam, where many babies are born in rural health centers, dispensing a critical birth-dose of hepatitis B vaccine can be challenging. We work with the immunization programs in Thanh Hoa and Hoa Binh provinces to deliver vaccine to newborns within 24 hours of birth.

Photo: Nguyen Ba Quang.

[View]

Vaccines are saving millions of lives every year, but poor countries still face many diseases without protection. We’re partnering with countries, donors, and the private sector to find solutions to prevent illnesses, such as pneumonia and influenza, and to help families and communities thrive.

Photo: Richard Lord.